Our preliminary analysis of pathological material indicates that for patients with secondary progressive MS, there is robust expression of MERTK in periplaque microglia, although the level of expression varies between specimens (Ranjan Dutta, personal communication), indicating that this phagocytic role is likely to be relevant to MS but of variable importance between individuals. This evidence concerns the gene MERTK and myeloid sarcoma.